6Vote!
PR News Wire (Free subscription) | 11/18/2009
WALTHAM, Mass., Nov. 18 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that sales of therapies to treat diabetic retinopathy, diabetic neuropathy and diabetic nephropathy will increase by more than 70 percent from $3.2 billion in 2008 to $5.5 billion in 2018 in the United States, France, Germany, Italy, Spain,...
3Vote!
NHS Evidence Specialist Collections News Alert (Free subscription) | 11/06/2009
An update of the evidence on this topic from NHS Evidence - diabetes. Get up-to-date with new systematic reviews that have been published in the last 12 months in the field of diabetes. The third Annual Evidence Update on Diabetes identifies new relevant systematic reviews on diabetes published between September 2008 and September 2009. For ease of use, the new evidence has been classified under the...
4Vote!
Business Wire (Free subscription) | 11/04/2009
MALVERN, Pa.--(BUSINESS WIRE)--Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today the publication of results from preclinical studies demonstrating that human Serum Amyloid P (hSAP) potently inhibited fibrosis in two independent model systems of kidney fibrosis. The study results indicate a potential role...
3Vote!
aarkstore | 10/29/2009
Diabetic Nephropathy Therapy Area Pipeline Report contains detailed information on the diabetic nephropathy drug pipeline. This report provides insight into the pipeline status of diabetic nephropathy drugs by company and by stage as well as a summary of the latest news and developments in this area. Scope of the report: Therapy Area Pipeline Report provides the user with real detail on drug pipelines,
5Vote!
Physorg (Free subscription) | 10/02/2009
For men with type 2 diabetes, a cell type linked to allergic inflammation is closely linked to a key indicator of diabetic kidney disease (nephropathy), suggests a study in the November Clinical Journal of the American Society of Nephrology (CJASN). "Allergy is a common disease that is increasing worldwide, so our findings may have important implications for diabetic nephropathy," comments...
3Vote!
Medical News Today (Free subscription) | 09/10/2009
NephroGenex, Inc., a privately held drug development company focusing on kidney disease, announced the completion of patient enrollment in its Phase 2b clinical trial (PYR-210) studying the safety and efficacy of its lead drug candidate Pyridorin(TM) (pyridoxamine dihydrochloride) in type 2 diabetic patients with overt diabetic nephropathy.
7Vote!
The Happy Hospitalist (Free subscription) | 08/23/2009
So Michael Jackson's cardiologist may have administered propofol to help him sleep. Not exactly an approved FDA indications. But should the doctor be charged with manslaughter? If he had died during surgery would he be charged with manslaughter? Dr WhiteCoat says: I’m not condoning what Dr. Murray did, but I also think society has to think very carefully before crossing the line between charges...
5Vote!
Physorg (Free subscription) | 08/04/2009
A marker of the likely course of diabetic nephropathy (DN) has been found. An 18-year study, published in the open access journal BMC Medicine, has shown that Immunoglobulin M (IgM) is a reliable predictor of cardiovascular complications in DN patients.
3Vote!
Uremic Frost (Free subscription) | 07/02/2009
Nephrologists have had a love affair with ACE inhibitors and Angiotensin receptor blockers since some great early data starting in the 1980s. Data has not been strong on the use of ACEi or ARBs very early on in diabetics without hypertension. Nevertheless, many Nephrologists (including myself) have given low doses of ACEi or ARBs in order to achieve renoprotection and delay (or avoid) any progression...
3Vote!
Nature Publishing Group (Free subscription) | 06/26/2009
The evaluation of diabetic nephropathy from research and clinical viewpoints depends on the assessment of two continuous variables, albumin excretion rate (AER) and glomerular filtration rate (GFR). These two parameters form the basis of both the European classification of five stages of diabetic nephropathy, assessed
1Vote!
Veggie Chic (Free subscription) | 06/02/2009
People with diabetes must be diligent in managing their blood glucose levels in order to prevent the more well-known diabetes complications, such as loss of vision (diabetic retinopathy), nerve pain (diabetic neuropathy), and kidney problems (diabetic nephropathy). But there are other illnesses that may occur in higher numbers in people with diabetes than in the [...] Post from: Blisstree Higher Colon...
3Vote!
aarkstore | 10/29/2009
Diabetic Nephropathy Therapy Area Pipeline Report contains detailed information on the diabetic nephropathy drug pipeline. This report provides insight into the pipeline status of diabetic nephropathy drugs by company and by stage as well as a summary of the latest news and developments in this area. Scope of the report: Therapy Area Pipeline Report provides the user with real detail on drug pipelines,...
Videos